Plerixafor
Plerixafor is a prescription medication that helps mobilize stem cells from the bone marrow into the bloodstream, often used before stem cell transplants in patients with certain cancers or blood disorders. It's administered as a subcutaneous injection, available as a 24 mg/1.2 mL solution (20 mg/mL) from Dr. Reddy's Laboratories. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Plerixafor is a prescription medication that helps mobilize stem cells from the bone marrow into the bloodstream, often used before stem cell transplants in patients with certain cancers or blood disorders. It's administered as a subcutaneous injection, available as a 24 mg/1.2 mL solution (20 mg/mL) from Dr. Reddy's Laboratories. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Plerixafor",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Plerixafor — ANDA 208980 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208980"
}
]
|
| identifier | ANDA208980 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Plerixafor |
